Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation

被引：36
|
作者：
Koyama, J [1 ]
Morita, I
Tagahara, K
Ogata, M
Mukainaka, T
Tokuda, H
Nishino, H
机构：
[1] Kobe Pharmaceut Univ, Fac Pharmaceut Sci, Kobe, Hyogo 658, Japan
[2] Kyoto Prefectural Univ Med, Dept Biochem, Kyoto 602, Japan
来源：
CANCER LETTERS | 2001年 / 170卷 / 01期
关键词：
anti-tumor promoting effect; Epstein-Barr virus activation; anthraquinone; bianthraquinone;
D O I：
10.1016/S0304-3835(01)00566-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Short-term in vitro assays for anti-tumor promoters were carried out for several anthraquinones and bianthraquinones, which were isolated from Cassia siamea and derived from cascaroside, A. Anthraquinone monomers showed higher anti-tumor promoting activity than that of bianthraquinones. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：15 / 18
页数：4
相关论文
共 50 条
  • [1] Inhibitory effects on Epstein-Barr virus activation of anthraquinones: Correlation with redox potentials
    Koyama, J
    Tagahara, K
    Osakai, T
    Tsujino, Y
    Tsurumi, S
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 1997, 115 (02) : 179 - 183
  • [2] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
    Sacau, EP
    Estévez-Braun, A
    Ravelo, AG
    Ferro, EA
    Tokuda, H
    Mukainaka, T
    Nishino, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
  • [3] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones
    Koyama, J
    Morita, I
    Kobayashi, N
    Osakai, T
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 2005, 225 (02) : 193 - 198
  • [4] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
    Inada, A
    Nakanishi, T
    Tokuda, H
    Nishina, H
    Iwashima, A
    Sharma, OP
    [J]. PLANTA MEDICA, 1995, 61 (06) : 558 - 559
  • [5] Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation
    Rahman, S
    Fukamiya, N
    Ohno, N
    Tokuda, H
    Nishino, H
    Tagahara, K
    Lee, KH
    Okano, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (04) : 675 - 677
  • [6] Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
    Koyama, J
    Morita, I
    Tagahara, K
    Osakai, T
    Hotta, H
    Yang, MX
    Mukainaka, T
    Nishino, H
    Tokuda, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (09) : 1214 - 1216
  • [7] Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products
    Akihisa, T
    Hamasaki, Y
    Tokuda, H
    Ukiya, M
    Kimura, Y
    Nishino, H
    [J]. JOURNAL OF NATURAL PRODUCTS, 2004, 67 (03): : 407 - 410
  • [8] Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation
    Uesato, S
    Taniuchi, K
    Kumagai, A
    Nagaoka, Y
    Seto, R
    Hara, Y
    Tokuda, H
    Nishino, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (12) : 1448 - 1450
  • [9] Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids
    Koyama, Junko
    Morita, Izumi
    Kobayashi, Norihiro
    Konoshima, Takao
    Takasaki, Midori
    Osakai, Toshiyuki
    Tokuda, Harukuni
    [J]. CANCER LETTERS, 2008, 263 (01) : 61 - 66
  • [10] Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
    Yiu, Ching-Yi
    Chen, Shih-Ying
    Chang, Li-Kwan
    Chiu, Ya-Fang
    Lin, Tsuey-Pin
    [J]. MOLECULES, 2010, 15 (10) : 7115 - 7124
12345